Cinnamon nudges blood sugar down in PCOS, but weight barely moves

Polycystic ovary syndrome is one of the most common hormonal disorders in women, and it carries a raised risk of cardiovascular problems over time. Anything cheap, familiar and safe that improves the metabolic picture, from blood sugar to cholesterol, is therefore worth testing properly. Cinnamon has a reputation for anti-inflammatory and insulin-sensitising properties, which makes it a plausible candidate rather than pure folklore. This review set out to establish whether the spice actually moves cardiovascular risk markers in women with the condition, instead of relying on scattered single trials.

The authors ran a systematic review and pooled the results of 12 randomised controlled trials in which women diagnosed with PCOS took cinnamon supplements and were compared with control groups. The primary outcomes were body weight, insulin resistance measured with the HOMA-IR score, and fasting blood sugar. The analysis also examined blood fats, including total cholesterol and LDL cholesterol. Results across trials were combined statistically, and the authors checked how consistently the individual trials agreed with each other.

Cinnamon supplementation produced a statistically significant but small reduction in body weight, averaging 0.47 kg. Fasting blood sugar fell by an average of 7.72 mg/dL, and insulin resistance scores improved. Total cholesterol dropped by 11.12 mg/dL on average and LDL cholesterol by 11.11 mg/dL. However, the trials disagreed substantially with one another, particularly on the blood sugar result, which makes the true size of these effects uncertain even though the direction was consistent.

This pooled analysis strengthens the case that cinnamon has genuine, if modest, metabolic effects in PCOS. It sits comfortably alongside the spice's broader reputation as an insulin-sensitising agent. That said, the review measured risk markers rather than actual cardiovascular events, so nobody knows whether these shifts translate into fewer heart problems down the line. The authors themselves call for larger trials with standardised methods, because the included studies varied considerably in how they were run.

For a reader with PCOS, this is a reason to see cinnamon as a plausible, low-cost adjunct that may nudge blood sugar, insulin resistance and cholesterol in the right direction, not a transformative treatment. The weight effect in particular, under half a kilogram, is too small to matter on its own. The findings come entirely from women with PCOS, so they say little about anyone else, and they describe average effects across trials rather than a guaranteed personal result.